Methodist Estabrook Cancer Center

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Head and neck cancer2 trials
• Ovarian cancer2 trials
• Prostate cancer2 trials
• Bladder cancer1 trial
• Colorectal cancer1 trial
• Endometrial cancer1 trial
• Gastric and oesophageal cancer1 trial
• Kidney cancer1 trial
• Liver and biliary tract cancer1 trial
• Lung cancer1 trial
• Melanoma1 trial
• Mesothelioma1 trial
• and 5 more

Phase

• Phase 33 trials

Status

• Recruiting2 trials
• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Alliance for Clinical Trials in Oncology1 trial
• Genmab1 trial
• Radiation Therapy Oncology Group1 trial
• University of Nebraska1 trial

Running trials

• Recruiting

  Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy

  NCT07225270· Phase 3· Genmab· Source

• Recruiting

  Integrated Cancer Repository for Cancer Research

  NCT02012699· University of Nebraska· Source

  Contact: Russell Smith, MD

• Active, not recruiting

  Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer

  NCT00430183· Phase 3· Alliance for Clinical Trials in Oncology· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Ovarian cancer2 recruiting
• Bladder cancer1 recruiting
• Colorectal cancer1 recruiting
• Endometrial cancer1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Head and neck cancer1 recruiting
• Kidney cancer1 recruiting
• Liver and biliary tract cancer1 recruiting
• Lung cancer1 recruiting
• Melanoma1 recruiting
• Mesothelioma1 recruiting
• Multiple myeloma1 recruiting
• Neuroendocrine tumours1 recruiting
• Pancreatic cancer1 recruiting
• Prostate cancer1 recruiting
• Sarcoma1 recruiting
• Thyroid cancer1 recruiting

Closed trials

• Completed

  Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer

  NCT01302834· Phase 3· Radiation Therapy Oncology Group· Source